| 5001 | Breast cancer (PheCode 174) | GCST90435600 | 1.78 |
| 5002 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T167 | ECGU000167 | 1.78 |
| 5003 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T396 | ECGA000396 | 1.78 |
| 5004 | IDP dMRI TBSS ICVF Cingulum hippocampus R | GCST90004363 | 1.77 |
| 5005 | IGSF8/NECTIN2 ratio | GCST90315140 | 1.77 |
| 5006 | Right-hemisphere control network to right-hemisphere default mode network white-matter structural connectivity | GCST90302835 | 1.77 |
| 5007 | aparc-Desikan lh area lingual | GCST90003085 | 1.77 |
| 5008 | triglyceride (minimum, inv-norm transformed) | GCST90476437 | 1.77 |
| 5009 | Abdominal aortic calcification levels | GCST90134614 | 1.76 |
| 5010 | Operative procedures - Fibreoptic endoscopic snare resection of lesion of colon | Summary Operations | UKBB00000579 | 1.76 |
| 5011 | COMP/DPP4 ratio | GCST90314188 | 1.76 |
| 5012 | Benign neoplasm: Sigmoid colon | FING00000203 | 1.76 |
| 5013 | Principal component-derived dietary pattern 27 | GCST90133032 | 1.76 |
| 5014 | Omega-6 fatty acids to total fatty acids percentage | GCST90502544 | 1.76 |
| 5015 | PALM2 levels | GCST90470152 | 1.76 |
| 5016 | Multiple myeloma and malignant plasma cell neoplasms (controls excluding all cancers) | FING00000843 | 1.75 |
| 5017 | IDP dMRI TBSS L3 Inferior cerebellar peduncle R | GCST90004181 | 1.75 |
| 5018 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T184 | ECGU000184 | 1.75 |
| 5019 | Free Cholesterol to Total Lipids in Large LDL percentage | GCST90498000 | 1.75 |
| 5020 | Systolic blood pressure | GCST90472781 | 1.75 |
| 5021 | Total bilirubin levels (UKB data field 30840) | GCST90468104 | 1.75 |
| 5022 | Cholesterol in Large LDL | GCST90497923 | 1.75 |
| 5023 | hemoglobin (mean, inv-norm transformed) | GCST90475376 | 1.75 |
| 5024 | CCL28/PDGFB ratio | GCST90313695 | 1.75 |
| 5025 | Remnant cholesterol (non-HDL, non-LDL -cholesterol) | GCST90499340 | 1.74 |
| 5026 | Saturated fatty acids levels (UKB data field 23448) | GCST90269545 | 1.74 |
| 5027 | Concentration of large LDL particles | GCST90498037 | 1.74 |
| 5028 | Phosphatidylethanolamine_35:2_[M-H]1- levels | GCST90060260 | 1.74 |
| 5029 | PDLIM7/PLA2G4A ratio | GCST90315637 | 1.74 |
| 5030 | Osteoarthrosis NOS | musculoskeletal | UKBB00000597 | 1.74 |
| 5031 | REST UKBBICA NET100 1212 | GCST90387066 | 1.74 |
| 5032 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T180 | ECGA000180 | 1.74 |
| 5033 | Waist-to-hip ratio adjusted for BMI | GCST90020025 | 1.74 |
| 5034 | IDP T1 FAST ROIs R mid front gyrus | GCST90002458 | 1.73 |
| 5035 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T185 | ECGU000185 | 1.73 |
| 5036 | Main speciality of consultant (recoded) - General surgery | Summary Administration | UKBB00000417 | 1.73 |
| 5037 | Milk chocolate liking | GCST90094801 | 1.73 |
| 5038 | Cholesteryl Esters in Small HDL | GCST90499386 | 1.73 |
| 5039 | Frozen shoulder | GCST90000513 | 1.73 |
| 5040 | DTI TBSS L3 Cingulum hippocampus R | GCST90384560 | 1.73 |
| 5041 | Triacylglycerol_52:5_[M+NH4]1+ levels | GCST90060506 | 1.73 |
| 5042 | GUSB levels | GCST90469421 | 1.72 |
| 5043 | aseg lh intensity Caudate | GCST90003769 | 1.72 |
| 5044 | HMBS/UBAC1 ratio | GCST90315066 | 1.72 |
| 5045 | ThalamNuclei lh volume Pf | GCST90002722 | 1.72 |
| 5046 | Recent feelings or nervousness or anxiety | Anxiety | UKBB00000741 | 1.72 |
| 5047 | Free cholesterol to total lipids ratio in IDL | GCST90092836 | 1.72 |
| 5048 | Benign lipomatous neoplasm | FING00000146 | 1.72 |
| 5049 | CNTN1/EGFR ratio | GCST90314162 | 1.72 |
| 5050 | CCN1/DNAJB1 ratio | GCST90313709 | 1.72 |
| 5051 | Urine 16a-hydroxy DHEA 3-sulfate levels in chronic kidney disease | GCST90264329 | 1.72 |
| 5052 | SSC5D levels | GCST90470748 | 1.72 |
| 5053 | Arterial embolism and thrombosis of lower extremity artery | FING00000106 | 1.72 |
| 5054 | IDP dMRI TBSS L3 Cerebral peduncle R | GCST90004185 | 1.71 |
| 5055 | DTI TBSS L2 External capsule R | GCST90384508 | 1.71 |
| 5056 | aseg lh intensity Thalamus-Proper | GCST90003768 | 1.71 |
| 5057 | ENO1 levels | GCST90469109 | 1.71 |
| 5058 | CPXM1/HBEGF ratio | GCST90314219 | 1.71 |
| 5059 | CDH1 levels | GCST90468670 | 1.71 |
| 5060 | KITLG levels | GCST90274833 | 1.71 |
| 5061 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T405 | ECGA000405 | 1.71 |
| 5062 | Been in a confiding relationship as an adult | Traumatic events | UKBB00000088 | 1.71 |
| 5063 | LCAT levels | GCST90469745 | 1.71 |
| 5064 | IDP T1 FAST ROIs V cerebellum crus II | GCST90002573 | 1.70 |
| 5065 | WAS levels | GCST90471071 | 1.70 |
| 5066 | TNFRSF11B levels | GCST90012002 | 1.70 |
| 5067 | CPA1/CTRC ratio | GCST90314204 | 1.70 |
| 5068 | GLOD4/HSPA1A ratio | GCST90314937 | 1.70 |
| 5069 | DTI TBSS FA Posterior thalamic radiation L | GCST90384409 | 1.70 |
| 5070 | Diacylglycerol_36:1_[M+H-H2O]1+ levels | GCST90060193 | 1.70 |
| 5071 | X-21829 levels | GCST90200585 | 1.70 |
| 5072 | Subarachnoid haemorrhage | FING00001339 | 1.70 |
| 5073 | Nontoxic nodular goiter (PheCode 241) | GCST90475638 | 1.70 |
| 5074 | GYS1/PPP1R2 ratio | GCST90315001 | 1.70 |
| 5075 | Conditional arithmetic | Fluid intelligence / reasoning | UKBB00000145 | 1.70 |
| 5076 | Free Cholesterol to Total Lipids in Very Small VLDL percentage | GCST90500791 | 1.70 |
| 5077 | MED18/SMAD1 ratio | GCST90315413 | 1.70 |
| 5078 | C1RL levels | GCST90468492 | 1.69 |
| 5079 | HYOU1/ROR1 ratio | GCST90315104 | 1.69 |
| 5080 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T423 | ECGU000423 | 1.69 |
| 5081 | X-26109 levels | GCST90200671 | 1.69 |
| 5082 | AmygNuclei rh volume Central-nucleus | GCST90002662 | 1.69 |
| 5083 | 2s,3R-dihydroxybutyrate levels | GCST90199882 | 1.69 |
| 5084 | Reticulocyte fraction of red cells | GCST004619 | 1.69 |
| 5085 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T183 | ECGA000183 | 1.68 |
| 5086 | CTSZ/HSPG2 ratio | GCST90314318 | 1.68 |
| 5087 | Hydrocephalus | FING00000628 | 1.68 |
| 5088 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T411 | ECGA000411 | 1.68 |
| 5089 | Aspartate aminotransferase (AST, maximum, inv-norm transformed) | GCST90475118 | 1.68 |
| 5090 | IDP dMRI ProbtrackX FA ar l | GCST90003925 | 1.68 |
| 5091 | Triglycerides to Total Lipids in IDL percentage | GCST90497676 | 1.68 |
| 5092 | Other specified cardiac dysrhythmias (PheCode 427.3) | GCST90475975 | 1.68 |
| 5093 | Free Cholesterol in LDL | GCST90498386 | 1.68 |
| 5094 | FSTL3 levels | GCST90469272 | 1.68 |
| 5095 | Phosphatidylcholine_34:2_[M+H]1+/Phosphatidylethanolamine_37:2_[M+H]1+/Phosphatidate_39:3_[M+NH4]1+ levels | GCST90060303 | 1.67 |
| 5096 | AmygNuclei rh volume Basal-nucleus | GCST90002659 | 1.67 |
| 5097 | Hydrocele | FING00000627 | 1.67 |
| 5098 | Total esterified cholesterol levels | GCST90092986 | 1.67 |
| 5099 | Total lipids in very large VLDL | GCST90500614 | 1.67 |
| 5100 | aparc-a2009s rh volume S-oc-middle+Lunatus | GCST90003055 | 1.67 |
| 5101 | Degree of unsaturation | GCST90502749 | 1.67 |
| 5102 | Hemoglobin concentration | GCST90002310 | 1.67 |
| 5103 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T13 | ECGU000013 | 1.67 |
| 5104 | DTI TBSS L2 Superior fronto-occipital fasciculus L | GCST90384519 | 1.67 |
| 5105 | Abnormal movement (PheCode 350) | GCST90475840 | 1.66 |
| 5106 | DLL4 levels | GCST90469005 | 1.66 |
| 5107 | Red cell distribution width | GCST90025988 | 1.66 |
| 5108 | Cholesteryl Esters to Total Lipids in Large LDL percentage | GCST90497967 | 1.66 |
| 5109 | Total cholesterol levels | GCST90092985 | 1.66 |
| 5110 | Seminoma of testis, excluding all cancers (controls excluding all cancers) | FING00001289 | 1.66 |
| 5111 | HYOU1/THBD ratio | GCST90315106 | 1.66 |
| 5112 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T464 | ECGA000464 | 1.66 |
| 5113 | Multi-trait sum score | GCST90270117 | 1.66 |
| 5114 | IDP dMRI ProbtrackX ISOVF slf l | GCST90004546 | 1.66 |
| 5115 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T166 | ECGU000166 | 1.66 |
| 5116 | Aneurysms, operations, SAH | FING00000085 | 1.66 |
| 5117 | aparc-pial lh area lateralorbitofrontal | GCST90003152 | 1.65 |
| 5118 | Cooked vegetable intake | Diet | UKBB00000147 | 1.65 |
| 5119 | AGRN/BTN2A1 ratio | GCST90313199 | 1.64 |
| 5120 | GRAP2/MAP4K5 ratio | GCST90314982 | 1.64 |
| 5121 | Tetradecadienedioate (C14:2-DC) metabolite level | GCST90616275 | 1.64 |
| 5122 | IL18BP/ROR1 ratio | GCST90315155 | 1.64 |
| 5123 | DTI autoptx L3 cgc r tract | GCST90385198 | 1.64 |
| 5124 | CD55 levels | GCST90468637 | 1.64 |
| 5125 | Light smokers, at least 100 smokes in lifetime | Smoking | UKBB00000407 | 1.64 |
| 5126 | DOK2/GRAP2 ratio | GCST90314531 | 1.64 |
| 5127 | Dupuytren's disease | GCST90301252 | 1.64 |
| 5128 | X-21364 levels | GCST90200566 | 1.64 |
| 5129 | NEO1 levels | GCST90470029 | 1.64 |
| 5130 | Triglycerides to Total Lipids in Small LDL percentage | GCST90499726 | 1.64 |
| 5131 | CALCOCO1/CASP3 ratio | GCST90313596 | 1.64 |
| 5132 | Obstructed labour due to maternal pelvic abnormality | FING00000899 | 1.63 |
| 5133 | Hearing aid use | GCST90044774 | 1.63 |
| 5134 | Diastolic blood pressure (BMI unadjusted) | GCST90335164 | 1.63 |
| 5135 | Cholesterol levels in chylomicrons and extremely large VLDL | GCST90500918 | 1.63 |
| 5136 | Coronary artery calcification | GCST90503074 | 1.63 |
| 5137 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T399 | ECGA000399 | 1.63 |
| 5138 | Lifespan | GCST90551884 | 1.63 |
| 5139 | Neutrophil count | GCST90018748 | 1.63 |
| 5140 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T159 | ECGU000159 | 1.63 |
| 5141 | Concentration of LDL particles | GCST90498413 | 1.63 |
| 5142 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 22) | GCST90320841 | 1.63 |
| 5143 | Cancer of bladder (PheCode 189.2) | GCST90475598 | 1.63 |
| 5144 | Migraine without aura and triptan purchases | FING00000822 | 1.62 |
| 5145 | Types of physical activity in last 4 weeks - Other exercises (eg: swimming, cycling, keep fit, bowling) | Physical activity | UKBB00000873 | 1.62 |
| 5146 | Right subiculum volume (body) | GCST90267980 | 1.62 |
| 5147 | AMBP/HYOU1 ratio | GCST90313255 | 1.62 |
| 5148 | Chronic obstructive pulmonary disease in never smokers | GCST90016589 | 1.62 |
| 5149 | Triglycerides to Total Lipids in Very Small VLDL percentage | GCST90500900 | 1.62 |
| 5150 | AIFM1/PLXNA4 ratio | GCST90313220 | 1.62 |
| 5151 | SCGB3A2 levels | GCST90470543 | 1.62 |
| 5152 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T245 | ECGU000245 | 1.62 |
| 5153 | IDP dMRI TBSS ISOVF Superior corona radiata R | GCST90004501 | 1.61 |
| 5154 | DYNLL1 levels | GCST90240984 | 1.61 |
| 5155 | Hematocrit | GCST90002305 | 1.61 |
| 5156 | QC tfMRI-to-T1 linear alignment discrepancy | GCST90006354 | 1.61 |
| 5157 | DTI autoptx L2 atr l tract | GCST90385168 | 1.60 |
| 5158 | Cholesterol in very large VLDL (UKB data field 23491) | GCST90269588 | 1.60 |
| 5159 | T1 FreeSurfer DK rh fusiform volume | GCST90385763 | 1.60 |
| 5160 | Medication use (calcium channel blockers) | GCST90018767 | 1.60 |
| 5161 | aparc-a2009s rh thickness G-temporal-middle | GCST90003714 | 1.60 |
| 5162 | Cholesterol levels in very large VLDL | GCST90093016 | 1.60 |
| 5163 | Acceptance of an invitation to wear a physical activity monitor | GCST90012791 | 1.60 |
| 5164 | NELL1 levels | GCST90470026 | 1.60 |
| 5165 | TIMP3/ZBTB16 ratio | GCST90315921 | 1.59 |
| 5166 | Pulmonary heart disease (PheCode 415) | GCST90475942 | 1.59 |
| 5167 | Total cholesterol levels | GCST90239675 | 1.59 |
| 5168 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T280 | ECGU000280 | 1.59 |
| 5169 | ADAM23 levels | GCST90468219 | 1.59 |
| 5170 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T429 | ECGU000429 | 1.59 |
| 5171 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T420 | ECGU000420 | 1.59 |
| 5172 | Total lipids in large VLDL | GCST90498216 | 1.59 |
| 5173 | Triglyceride levels in medium VLDL | GCST90092926 | 1.59 |
| 5174 | IDP dMRI ProbtrackX FA cst r | GCST90003934 | 1.59 |
| 5175 | IDP dMRI ProbtrackX L1 cgc r | GCST90004251 | 1.59 |
| 5176 | DTI autoptx L1 ptr r tract | GCST90385159 | 1.59 |
| 5177 | SERPINA12 levels | GCST90470581 | 1.59 |
| 5178 | NECTIN2/SDC1 ratio | GCST90315529 | 1.59 |
| 5179 | APOA1 levels | GCST90497119 | 1.59 |
| 5180 | C1R levels | GCST90468493 | 1.58 |
| 5181 | Overweight, obesity and other hyperalimentation (PheCode 278) | GCST90475759 | 1.58 |
| 5182 | Free cholesterol levels in large VLDL | GCST90092872 | 1.58 |
| 5183 | Cholesteryl Esters to Total Lipids in Very Small VLDL percentage | GCST90500754 | 1.58 |
| 5184 | Suicide or other Intentional self-harm | FING00001345 | 1.58 |
| 5185 | F-seafood liking (derived food-liking factor) | GCST90094836 | 1.58 |
| 5186 | IDP dMRI ProbtrackX ICVF cgc r | GCST90004380 | 1.58 |
| 5187 | Mean arterial pressure (BMI unadjusted) | GCST90335168 | 1.58 |
| 5188 | Cholesterol to Total Lipids in Small LDL percentage | GCST90499569 | 1.58 |
| 5189 | MYOC/RGMB ratio | GCST90315508 | 1.57 |
| 5190 | Mean corpuscular hemoglobin | GCST004630 | 1.57 |
| 5191 | BCAN/MOG ratio | GCST90313480 | 1.57 |
| 5192 | CD300C/LRRC25 ratio | GCST90313790 | 1.57 |
| 5193 | COL1A1/SOST ratio | GCST90314172 | 1.57 |
| 5194 | CD58/MEGF10 ratio | GCST90313853 | 1.57 |
| 5195 | INSL5 levels | GCST90469622 | 1.57 |
| 5196 | Do you currently smoke cigarettes? | GCST90476388 | 1.57 |
| 5197 | IDP T1 FAST ROIs R parietal operc cortex | GCST90002536 | 1.57 |
| 5198 | Colon polyps | GCST90475319 | 1.57 |
| 5199 | Triglyceride levels in small LDL | GCST90092966 | 1.56 |
| 5200 | Docosahexaenoic acid to total fatty acids percentage (UKB data field 23457) | GCST90269554 | 1.56 |
| 5201 | Non-allergic asthma (mode) (more control exclusions) | FING00000869 | 1.56 |
| 5202 | ATXN10/CASP10 ratio | GCST90313396 | 1.56 |
| 5203 | X-12063 levels | GCST90243687 | 1.56 |
| 5204 | Cholesterol to total lipids ratio in large VLDL | GCST90092869 | 1.56 |
| 5205 | FABP5/PPCDC ratio | GCST90314763 | 1.56 |
| 5206 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T279 | ECGU000279 | 1.56 |
| 5207 | IL31RA levels | GCST90469589 | 1.56 |
| 5208 | aparc-Desikan rh thickness postcentral | GCST90003500 | 1.56 |
| 5209 | Left-hemisphere limbic network to right-hemisphere dorsal attention network white-matter structural connectivity | GCST90302731 | 1.56 |
| 5210 | Intra-ocular pressure, Goldmann-correlated (right) | Intraocular pressure | UKBB00000377 | 1.56 |
| 5211 | Leucine levels | GCST90092891 | 1.56 |
| 5212 | Fractured bone site(s) - Other bones | Medical conditions | UKBB00000256 | 1.56 |
| 5213 | Plasma methylsuccinate levels in chronic kidney disease | GCST90265506 | 1.55 |
| 5214 | SMAD5 levels | GCST90470678 | 1.55 |
| 5215 | Triglycerides in HDL | GCST90497464 | 1.55 |
| 5216 | Pain in limb | FING00001138 | 1.54 |
| 5217 | Phospholipids in small HDL | GCST90499483 | 1.54 |
| 5218 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T278 | ECGU000278 | 1.54 |
| 5219 | MSTN levels | GCST90469953 | 1.54 |
| 5220 | Attention deficit hyperactivity disorder (adjusted for age, sex) | GCST90275147 | 1.54 |
| 5221 | COPD | FING00000350 | 1.54 |
| 5222 | CA2/HMBS ratio | GCST90313579 | 1.54 |
| 5223 | Right-hemisphere visual network to right-hemisphere somatomotor network white-matter structural connectivity | GCST90302775 | 1.54 |
| 5224 | AGRN/CRIM1 ratio | GCST90313200 | 1.54 |
| 5225 | CPM levels | GCST90240598 | 1.53 |
| 5226 | PDLIM7/SRC ratio | GCST90315639 | 1.53 |
| 5227 | Alanine levels | GCST003666 | 1.53 |
| 5228 | CETN3 levels | GCST90468722 | 1.53 |
| 5229 | Anaemias | FING00000082 | 1.53 |
| 5230 | IDP dMRI TBSS L2 Cerebral peduncle R | GCST90004137 | 1.53 |
| 5231 | Tense / 'highly strung' | Mental health | UKBB00000815 | 1.53 |
| 5232 | KIFBP/LYN ratio | GCST90315246 | 1.53 |
| 5233 | aparc-a2009s lh thickness S-cingul-Marginalis | GCST90003648 | 1.53 |
| 5234 | Proline levels | GCST90243457 | 1.53 |
| 5235 | DTI TBSS L3 Superior corona radiata R | GCST90384548 | 1.53 |
| 5236 | PRDX3 levels | GCST90470317 | 1.52 |
| 5237 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 81) | GCST90320644 | 1.52 |
| 5238 | ADAMTS15 levels | GCST90468223 | 1.52 |
| 5239 | Triglycerides in VLDL | GCST90500295 | 1.52 |
| 5240 | Depression | GCST003769 | 1.52 |
| 5241 | Phospholipids in HDL | GCST90497430 | 1.52 |
| 5242 | Lysoalkylphosphatidylcholine (O-22:0) levels | GCST90024195 | 1.51 |
| 5243 | APOB levels | GCST90497137 | 1.51 |
| 5244 | Essential hypertension (PheCode 401.1) | GCST90475922 | 1.51 |
| 5245 | Forced expiratory volume in 1-second (FEV1), predicted percentage | Spirometry | UKBB00000253 | 1.51 |
| 5246 | COL6A3/COLEC12 ratio | GCST90314173 | 1.51 |
| 5247 | CD300E/LILRA5 ratio | GCST90313798 | 1.51 |
| 5248 | Coffee type: Decaffeinated coffee (any type) (UKB data field 1508_1) | GCST90132974 | 1.51 |
| 5249 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T182 | ECGU000182 | 1.51 |
| 5250 | Benign neoplasm: Adrenal gland | FING00000164 | 1.51 |
| 5251 | Cholesterol to Total Lipids in Medium LDL percentage | GCST90498714 | 1.51 |
| 5252 | Docosahexaenoic acid to total fatty acids percentage | GCST90502269 | 1.50 |
| 5253 | Free cholesterol in small LDL | GCST90499620 | 1.50 |
| 5254 | Alpha-hydroxyisovalerate levels | GCST90199736 | 1.50 |
| 5255 | IDP dMRI TBSS L3 Retrolenticular part of internal capsule L | GCST90004192 | 1.50 |
| 5256 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T393 | ECGA000393 | 1.50 |
| 5257 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T176 | ECGA000176 | 1.49 |
| 5258 | Dementia | FING00000391 | 1.49 |
| 5259 | Free Cholesterol to Total Lipids in Medium LDL percentage | GCST90498783 | 1.49 |
| 5260 | PSME2/RBKS ratio | GCST90315737 | 1.49 |
| 5261 | Concentration of small LDL particles | GCST90499660 | 1.49 |
| 5262 | Hypertensive heart and/or renal disease (PheCode 401.2) | GCST90475924 | 1.49 |
| 5263 | HippSubfield rh volume CA1-body | GCST90002692 | 1.49 |
| 5264 | IDP dMRI TBSS L2 Pontine crossing tract | GCST90004124 | 1.49 |
| 5265 | T1 FreeSurfer DKT rh pericalcarine area | GCST90384305 | 1.49 |
| 5266 | PCDH17/PTPRM ratio | GCST90315603 | 1.49 |
| 5267 | aparc-a2009s rh volume S-oc-temp-med+Lingual | GCST90003059 | 1.49 |
| 5268 | AOC3 levels | GCST90468322 | 1.48 |
| 5269 | wg lh intensity-contrast insula | GCST90003826 | 1.48 |
| 5270 | MANF/PTPN6 ratio | GCST90315366 | 1.48 |
| 5271 | Invitation to complete online 24-hour recall dietary questionnaire, acceptance | Online follow-up - Diet by 24-hour recall | UKBB00000378 | 1.48 |
| 5272 | Cholesterol to Total Lipids in Medium HDL percentage | GCST90498519 | 1.48 |
| 5273 | EDAR/TACC3 ratio | GCST90314589 | 1.48 |
| 5274 | HippSubfield rh volume subiculum-body | GCST90002691 | 1.48 |
| 5275 | Type 2 diabetes, wide definition | FING00001383 | 1.48 |
| 5276 | Cancer code, self-reported: prostate cancer (UKB data field 20001_1044) | GCST90041905 | 1.48 |
| 5277 | Chronic hepatitis C infection | GCST90018585 | 1.48 |
| 5278 | Left-hemisphere visual network to caudate white-matter structural connectivity | GCST90302663 | 1.48 |
| 5279 | Fractured/broken bones in last 5 years | Medical conditions | UKBB00000258 | 1.48 |
| 5280 | Left ventricular stroke volume | GCST90268130 | 1.47 |
| 5281 | Acetate levels (UKB data field 23475) | GCST90269572 | 1.47 |
| 5282 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T406 | ECGA000406 | 1.47 |
| 5283 | Omega-6 fatty acid levels | GCST90502100 | 1.47 |
| 5284 | Erectile dysfunction | GCST006956 | 1.47 |
| 5285 | Triglycerides to Total Lipids in Medium LDL percentage | GCST90498885 | 1.47 |
| 5286 | CA2/TGM2 ratio | GCST90313582 | 1.47 |
| 5287 | Left hippocampal volume (body) | GCST90267948 | 1.47 |
| 5288 | aseg lh intensity Putamen | GCST90003770 | 1.47 |
| 5289 | IGFBP6 levels | GCST90469531 | 1.47 |
| 5290 | GASK1A levels | GCST90469306 | 1.47 |
| 5291 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 43) | GCST90320606 | 1.46 |
| 5292 | CD74/IL18BP ratio | GCST90313892 | 1.46 |
| 5293 | Congenital lactase deficiency | FING00000329 | 1.46 |
| 5294 | Daytime nap | GCST011494 | 1.46 |
| 5295 | GRP levels | GCST90469406 | 1.46 |
| 5296 | Myocardial infarction | GCST90018657 | 1.46 |
| 5297 | BA-exvivo lh thickness MT | GCST90003524 | 1.46 |
| 5298 | SOST levels | GCST90470711 | 1.46 |
| 5299 | CDKN1A/YES1 ratio | GCST90313980 | 1.46 |
| 5300 | CDKN1A/DAB2 ratio | GCST90313967 | 1.46 |
| 5301 | Fruit liking | GCST90094766 | 1.46 |
| 5302 | MAVS/PPP1R9B ratio | GCST90315393 | 1.45 |
| 5303 | Left-hemisphere salience/ventral attention network to right-hemisphere somatomotor network white-matter structural connectivity | GCST90302713 | 1.45 |
| 5304 | Principal component-derived dietary pattern 14 | GCST90133019 | 1.45 |
| 5305 | MINPP1 levels | GCST90241978 | 1.45 |
| 5306 | Celiac disease (PheCode 557.1) | GCST90044158 | 1.45 |
| 5307 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T426 | ECGU000426 | 1.45 |
| 5308 | Irritable bowel syndrome | FING00000702 | 1.45 |
| 5309 | IDP dMRI ProbtrackX ICVF slf r | GCST90004397 | 1.45 |
| 5310 | FADD/LACTB2 ratio | GCST90314767 | 1.45 |
| 5311 | Cholesterol to Total Lipids in Large LDL percentage | GCST90497938 | 1.44 |
| 5312 | Free Cholesterol to Total Lipids in Medium HDL percentage | GCST90498583 | 1.44 |
| 5313 | EDAR/ERBIN ratio | GCST90314575 | 1.44 |
| 5314 | Ever highly irritable/argumentative for 2 days | Mental health | UKBB00000219 | 1.44 |
| 5315 | Cholesteryl esters to total lipids ratio in very large HDL | GCST90093007 | 1.44 |
| 5316 | CD163/ICAM1 ratio | GCST90313735 | 1.44 |
| 5317 | rfMRI connectivity (ICA100 edge 951) | GCST90005804 | 1.44 |
| 5318 | Vanillylmandelate (VMA) levels | GCST90200309 | 1.44 |
| 5319 | Pregnancy with abortive outcome | FING00001205 | 1.44 |
| 5320 | Platelet count during second trimester of pregnancy | GCST90302225 | 1.43 |
| 5321 | DTI autoptx L2 slf l tract | GCST90385187 | 1.43 |
| 5322 | PON3 levels | GCST90470287 | 1.43 |
| 5323 | GDNF levels | GCST90274792 | 1.43 |
| 5324 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T463 | ECGA000463 | 1.43 |
| 5325 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 85) | GCST90320904 | 1.43 |
| 5326 | Polyunsaturated fatty acids to monounsaturated fatty acids ratio | GCST90502570 | 1.42 |
| 5327 | ENO2/HCLS1 ratio | GCST90314660 | 1.42 |
| 5328 | Left hippocampal volume | GCST90267952 | 1.42 |
| 5329 | Omega-6 fatty acids levels | GCST90499170 | 1.42 |
| 5330 | IDP dMRI TBSS ICVF Cingulum hippocampus L | GCST90004364 | 1.42 |
| 5331 | Total lipids in small LDL | GCST90499652 | 1.42 |
| 5332 | Bicarbonate (maximum, inv-norm transformed) | GCST90475145 | 1.42 |
| 5333 | Right-hemisphere dorsal attention network to right-hemisphere default mode network white-matter structural connectivity | GCST90302805 | 1.41 |
| 5334 | High light scatter reticulocyte count | GCST004611 | 1.41 |
| 5335 | LHPP levels | GCST90469768 | 1.41 |
| 5336 | wg lh intensity-contrast entorhinal | GCST90003797 | 1.41 |
| 5337 | HYOU1 levels | GCST90469496 | 1.41 |
| 5338 | TNFRSF11B levels | GCST90470903 | 1.41 |
| 5339 | HippSubfield lh volume Whole-hippocampal-head | GCST90002688 | 1.40 |
| 5340 | INHBC levels | GCST90469615 | 1.40 |
| 5341 | Systolic blood pressure | GCST90472782 | 1.40 |
| 5342 | hematocrit (mean, inv-norm transformed) | GCST90475341 | 1.40 |
| 5343 | Risk taking (standard GWA) | GCST90267298 | 1.40 |
| 5344 | DTI autoptx L3 ifo l tract | GCST90385205 | 1.40 |
| 5345 | Triglycerides to Total Lipids in Medium VLDL percentage | GCST90499069 | 1.40 |
| 5346 | Phosphatidylcholine-O_36:2_[M+H]1+/Phosphatidylcholine-P_36:1_[M+H]1+/Phosphatidylethanolamine-P_39:1_[M+H]1+ levels | GCST90060326 | 1.40 |
| 5347 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T284 | ECGU000284 | 1.40 |
| 5348 | Drive faster than motorway speed limit | Physical activity | UKBB00000194 | 1.40 |
| 5349 | Phospholipids to total lipids in large VLDL percentage (UKB data field 23589) | GCST90269686 | 1.40 |
| 5350 | BCAM/LGALS4 ratio | GCST90313473 | 1.40 |
| 5351 | Kynurenine levels | GCST90243477 | 1.40 |
| 5352 | ITGB1BP2/STAT5B ratio | GCST90315220 | 1.40 |
| 5353 | Phospholipids to total lipids ratio in large VLDL | GCST90092877 | 1.40 |
| 5354 | SGSH levels | GCST90470615 | 1.39 |
| 5355 | BIN2/EREG ratio | GCST90313503 | 1.39 |
| 5356 | aseg rh intensity Cerebellum-Cortex | GCST90003781 | 1.39 |
| 5357 | CIAPIN1 levels | GCST90468753 | 1.39 |
| 5358 | CRADD/FKBP4 ratio | GCST90314238 | 1.39 |
| 5359 | X-16087 levels | GCST90200537 | 1.39 |
| 5360 | ITGB1/NCAM1 ratio | GCST90315227 | 1.39 |
| 5361 | Cancer of liver and intrahepatic bile duct (PheCode 155) | GCST90475568 | 1.39 |
| 5362 | Phospholipids in medium LDL | GCST90498832 | 1.39 |
| 5363 | CYTL1 levels | GCST90468940 | 1.39 |
| 5364 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 3) | GCST90320566 | 1.38 |
| 5365 | Diabetes, insulin treatment (Kela reimbursement) (more control exclusions) | FING00000410 | 1.38 |
| 5366 | IDP dMRI TBSS L1 External capsule R | GCST90004107 | 1.38 |
| 5367 | ICD10 O14: Pre-eclampsia | GCST90454233 | 1.38 |
| 5368 | wg lh intensity-contrast medialorbitofrontal | GCST90003805 | 1.38 |
| 5369 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 65) | GCST90320884 | 1.38 |
| 5370 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 60) | GCST90320623 | 1.38 |
| 5371 | CLEC4G/KEL ratio | GCST90314119 | 1.38 |
| 5372 | Major depressive disorder (ICD-10 coded) | GCST005903 | 1.38 |
| 5373 | Total testosterone levels | GCST90239819 | 1.38 |
| 5374 | Glaucoma | GCST90475869 | 1.38 |
| 5375 | Free cholesterol in very small VLDL (UKB data field 23521) | GCST90269618 | 1.38 |
| 5376 | CXCL11/CXCL13 ratio | GCST90314333 | 1.37 |
| 5377 | IGSF3 levels | GCST90469539 | 1.37 |
| 5378 | IDP dMRI TBSS FA Posterior limb of internal capsule L | GCST90003896 | 1.37 |
| 5379 | NXPH3 levels | GCST90470112 | 1.37 |
| 5380 | CTF1 levels | GCST90468901 | 1.37 |
| 5381 | IDP dMRI ProbtrackX FA str l | GCST90003948 | 1.37 |
| 5382 | ABHD14B/SCRN1 ratio | GCST90313145 | 1.37 |
| 5383 | Osteomyelitis, periostitis, and other infections involving bone (PheCode 710) | GCST90476220 | 1.37 |
| 5384 | Total lipids in VLDL (UKB data field 23424) | GCST90269521 | 1.37 |
| 5385 | DTI TBSS MD Fornix | GCST90384577 | 1.37 |
| 5386 | Total cholesterol levels in HDL | GCST90132681 | 1.37 |
| 5387 | aparc-Desikan rh area precentral | GCST90003130 | 1.36 |
| 5388 | WARS levels | GCST90471066 | 1.36 |
| 5389 | Prostate cancer | GCST90274716 | 1.36 |
| 5390 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T410 | ECGA000410 | 1.36 |
| 5391 | CD4 levels | GCST90468636 | 1.36 |
| 5392 | CTRB1/PLA2G1B ratio | GCST90314307 | 1.36 |
| 5393 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T376 | ECGU000376 | 1.36 |
| 5394 | TIRAP levels | GCST90243032 | 1.36 |
| 5395 | Left-hemisphere default mode network to right-hemisphere visual network white-matter structural connectivity | GCST90302760 | 1.36 |
| 5396 | Cholesterol in very small VLDL (UKB data field 23519) | GCST90269616 | 1.36 |
| 5397 | aparc-pial lh area precuneus | GCST90003165 | 1.36 |
| 5398 | CD34 levels | GCST90468626 | 1.35 |
| 5399 | ACVRL1/TNFRSF10B ratio | GCST90313158 | 1.35 |
| 5400 | Free Cholesterol to Total Lipids in Small LDL percentage | GCST90499635 | 1.35 |
| 5401 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T456 | ECGU000456 | 1.35 |
| 5402 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T404 | ECGA000404 | 1.35 |
| 5403 | Average diameter for VLDL particles (UKB data field 23431) | GCST90269528 | 1.35 |
| 5404 | GP5 levels | GCST90469383 | 1.35 |
| 5405 | Total free cholesterol levels | GCST90500063 | 1.35 |
| 5406 | TNFRSF12A levels | GCST90470904 | 1.35 |
| 5407 | Total triglycerides levels | GCST90500140 | 1.34 |
| 5408 | CPA1 levels | GCST90468836 | 1.34 |
| 5409 | TMPRSS15 levels | GCST90470892 | 1.34 |
| 5410 | Cellulitis and abscess of leg, except foot (PheCode 681.5) | GCST90476166 | 1.34 |
| 5411 | Triacylglycerol_46:4_[M+NH4]1+ levels | GCST90060362 | 1.34 |
| 5412 | Intrinsic epigenetic age acceleration | GCST90014290 | 1.34 |
| 5413 | GYS1/TIA1 ratio | GCST90315004 | 1.34 |
| 5414 | PSMG3 levels | GCST90470362 | 1.34 |
| 5415 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T462 | ECGA000462 | 1.34 |
| 5416 | DNA methylation GrimAge acceleration | GCST90014288 | 1.34 |
| 5417 | TIA1/USP8 ratio | GCST90315920 | 1.34 |
| 5418 | CD163/DSC2 ratio | GCST90313733 | 1.34 |
| 5419 | Smoking/smokers in household | Smoking | UKBB00000783 | 1.34 |
| 5420 | Secondary thrombocytopenia (PheCode 287.32) | GCST90475810 | 1.33 |
| 5421 | wg rh intensity-contrast parsorbitalis | GCST90003845 | 1.33 |
| 5422 | Retinal detachment with retinal defect | sense organs | UKBB00000754 | 1.33 |
| 5423 | Heart rate variability (corrected root mean square of successive differences) | GCST90281264 | 1.33 |
| 5424 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T408 | ECGA000408 | 1.33 |
| 5425 | CLEC14A/EPHB4 ratio | GCST90314079 | 1.33 |
| 5426 | IDP dMRI TBSS ICVF Anterior limb of internal capsule L | GCST90004344 | 1.33 |
| 5427 | Right-hemisphere somatomotor network to thalamus white-matter structural connectivity | GCST90302794 | 1.33 |
| 5428 | 3,4-dihydroxybutyrate levels | GCST90199816 | 1.33 |
| 5429 | Glaucoma (primary open-angle) | GCST90011768 | 1.33 |
| 5430 | F-strong vegetable liking (derived food-liking factor) | GCST90094852 | 1.33 |
| 5431 | Cardiovascular delta age (difference between cardiac MRI-predicted and chronological age) | GCST90239748 | 1.33 |
| 5432 | IDP dMRI TBSS ICVF Fornix cres+Stria terminalis R | GCST90004365 | 1.33 |
| 5433 | Docosahexaenoic acid levels | GCST90497256 | 1.33 |
| 5434 | Tyrosine levels | GCST90200427 | 1.33 |
| 5435 | Total lipid levels in IDL | GCST90092837 | 1.33 |
| 5436 | Concentration of medium LDL particles | GCST90092911 | 1.33 |
| 5437 | Plasma glycocholenate sulfate* levels in chronic kidney disease | GCST90265291 | 1.32 |
| 5438 | Volume of left lateral nucleus | GCST90474973 | 1.32 |
| 5439 | ELOA/POLR2F ratio | GCST90314643 | 1.32 |
| 5440 | High light scatter reticulocyte percentage of red cells | GCST004612 | 1.32 |
| 5441 | CEACAM1 levels | GCST90468692 | 1.32 |
| 5442 | Corneal resistance factor | GCST90308682 | 1.32 |
| 5443 | aseg lh volume Accumbens-area | GCST90002626 | 1.32 |
| 5444 | CKAP4/IL4R ratio | GCST90314072 | 1.32 |
| 5445 | Ischemic heart disease (PheCode 411) | GCST008370 | 1.32 |
| 5446 | Triacylglycerol_53:3_[M+NH4]1+ levels | GCST90060528 | 1.32 |
| 5447 | FXN/TRIAP1 ratio | GCST90314899 | 1.32 |
| 5448 | Clinical LDL cholesterol levels | GCST90497219 | 1.32 |
| 5449 | Prescriptions - calcium channel blocker|dihydropyridine|anti-hypertensive | UKBB00000673 | 1.32 |
| 5450 | CCL16 levels | GCST90179243 | 1.32 |
| 5451 | CLIP2/DNAJA2 ratio | GCST90314127 | 1.31 |
| 5452 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 72) | GCST90320891 | 1.31 |
| 5453 | BCAM/ICAM4 ratio | GCST90313472 | 1.31 |
| 5454 | IDP dMRI TBSS OD Superior fronto-occipital fasciculus L | GCST90004445 | 1.31 |
| 5455 | Hypertensive chronic kidney disease (PheCode 401.22) | GCST90475927 | 1.31 |
| 5456 | FST levels | GCST90012080 | 1.31 |
| 5457 | FUT3 levels | GCST90241216 | 1.31 |
| 5458 | REST UKBBICA NODEamps25 0014 | GCST90385497 | 1.31 |
| 5459 | CD300LG levels | GCST90468623 | 1.31 |
| 5460 | T1 FreeSurfer aseg MaskVol-to-eTIV | GCST90384192 | 1.31 |
| 5461 | Non-cancer illness code, self-reported - diabetes | Medical conditions | UKBB00000508 | 1.31 |
| 5462 | Phosphatidylcholine-O_34:2_[M+H]1+/Phosphatidylcholine-P_34:1_[M+H]1+/Phosphatidylethanolamine-O_37:2_[M+H]1+ levels | GCST90060280 | 1.31 |
| 5463 | CKB levels | GCST90468759 | 1.31 |
| 5464 | Nontoxic diffuse goitre | FING00000886 | 1.31 |
| 5465 | Concentration of very small VLDL particles | GCST90093035 | 1.31 |
| 5466 | Glucose levels (UKB data field 23470) | GCST90269567 | 1.30 |
| 5467 | Cholesteryl esters to total lipids ratio in medium LDL | GCST90092907 | 1.30 |
| 5468 | rfMRI connectivity (ICA100 edge 931) | GCST90005784 | 1.30 |
| 5469 | COPD-related respiratory insufficiency | FING00000352 | 1.30 |
| 5470 | Triglyceride levels in very small VLDL | GCST90093038 | 1.30 |
| 5471 | Atrial fibrillation and flutter | Other forms of heart disease | UKBB00000056 | 1.30 |
| 5472 | Left-hemisphere limbic network to amygdala white-matter structural connectivity | GCST90302741 | 1.30 |
| 5473 | DBNL/HEXIM1 ratio | GCST90314417 | 1.30 |
| 5474 | Cake icing liking | GCST90094723 | 1.30 |
| 5475 | MAP3K5/ZBTB16 ratio | GCST90315380 | 1.30 |
| 5476 | Impacted cerumen (PheCode 380.4) | GCST90475901 | 1.30 |
| 5477 | Cholesteryl Esters to Total Lipids in Large VLDL percentage | GCST90498165 | 1.30 |
| 5478 | MME levels | GCST90469914 | 1.30 |
| 5479 | Triacylglycerol_53:5_[M+NH4]1+ levels | GCST90060520 | 1.29 |
| 5480 | Urinary albumin-to-creatinine ratio | GCST009640 | 1.29 |
| 5481 | Phospholipid levels in IDL | GCST90092839 | 1.29 |
| 5482 | Retinal detachments and defects | sense organs | UKBB00000756 | 1.29 |
| 5483 | AHSP/HMBS ratio | GCST90313217 | 1.29 |
| 5484 | Diacylglycerol_42:7_[M+H-H2O]1+ levels | GCST90060226 | 1.29 |
| 5485 | Atrial fibrillation and flutter | circulatory system | UKBB00000055 | 1.29 |
| 5486 | Right-hemisphere somatomotor network to caudate white-matter structural connectivity | GCST90302795 | 1.29 |
| 5487 | PRKRA levels | GCST90470331 | 1.28 |
| 5488 | CCL11 levels | GCST90274764 | 1.28 |
| 5489 | Alcohol intake versus 10 years previously | Alcohol | UKBB00000024 | 1.28 |
| 5490 | Abdominal aortic aneurysm (AAA) | FING00000001 | 1.28 |
| 5491 | Ischemic stroke | GCST006908 | 1.28 |
| 5492 | Ever Smoker | FING00000522 | 1.28 |
| 5493 | Inpatient record format - UK HES In Patient (2015 format) | Summary Administration | UKBB00000364 | 1.28 |
| 5494 | Duration screen displayed | Prospective memory | UKBB00000201 | 1.28 |
| 5495 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T407 | ECGA000407 | 1.28 |
| 5496 | DOK2/PDLIM7 ratio | GCST90314535 | 1.27 |
| 5497 | Chronic renal failure [CKD] (PheCode 585.3) | GCST90476123 | 1.27 |
| 5498 | SCGB1A1 levels | GCST90470540 | 1.27 |
| 5499 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T395 | ECGA000395 | 1.27 |
| 5500 | IDP T1 FIRST left pallidum volume | GCST90002442 | 1.27 |
| 5501 | NMNAT1 levels | GCST90470057 | 1.27 |
| 5502 | DAB2/ZBTB16 ratio | GCST90314370 | 1.27 |
| 5503 | Calculus of kidney and ureter | FING00000236 | 1.26 |
| 5504 | Cholesteryl Esters to Total Lipids in Small LDL percentage | GCST90499595 | 1.26 |
| 5505 | DTI TBSS MD Anterior limb of internal capsule L | GCST90384589 | 1.26 |
| 5506 | Hypertension (PheCode 401) | GCST90475919 | 1.26 |
| 5507 | Bioavailable testosterone levels | GCST90012102 | 1.26 |
| 5508 | RTBDN levels | GCST90470505 | 1.26 |
| 5509 | ROR1 levels | GCST90470492 | 1.26 |
| 5510 | Polyunsaturated fatty acids to saturated fatty acids ratio | GCST90502168 | 1.26 |
| 5511 | Clonal haematopoiesis of indeterminate potential (TET2 mutation) | GCST90165281 | 1.26 |
| 5512 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T474 | ECGA000474 | 1.26 |
| 5513 | Malignant neoplasm, excluding all cancers (controls excluding all cancers) | FING00000780 | 1.26 |
| 5514 | aparc-Desikan lh thickness GlobalMeanThickness | GCST90003445 | 1.26 |
| 5515 | Fresh fruit intake | Diet | UKBB00000272 | 1.26 |
| 5516 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T409 | ECGA000409 | 1.26 |
| 5517 | IDP dMRI TBSS FA Anterior limb of internal capsule R | GCST90003893 | 1.26 |
| 5518 | Right hippocampal volume | GCST90267974 | 1.26 |
| 5519 | Phospholipids to Total Lipids in Large LDL percentage | GCST90498071 | 1.25 |
| 5520 | Total lipids in lipoprotein particles (UKB data field 23423) | GCST90269520 | 1.25 |
| 5521 | Alpha angle | GCST90129635 | 1.25 |
| 5522 | Cholesterol to total lipids in medium HDL percentage (UKB data field 23640) | GCST90269737 | 1.25 |
| 5523 | Nonalcoholic fatty liver disease | FING00000878 | 1.25 |
| 5524 | Saturated fatty acids to total fatty acids percentage | GCST90502684 | 1.25 |
| 5525 | Telomere length (principal component 1) | GCST90435144 | 1.25 |
| 5526 | NOTCH1 levels | GCST90470065 | 1.25 |
| 5527 | Atrial flutter (PheCode 427.22) | GCST90475973 | 1.24 |
| 5528 | Chronic hepatitis B infection | GCST90018584 | 1.24 |
| 5529 | Disorder of skin and subcutaneous tissue NO (PheCode 689) | GCST90476169 | 1.24 |
| 5530 | Type 1 diabetes with ophthalmic manifestations (PheCode 250.13) | GCST90475663 | 1.24 |
| 5531 | CAG-177 abundance in stool | GCST90032261 | 1.24 |
| 5532 | Red blood cell count | GCST90018751 | 1.24 |
| 5533 | IDP dMRI ProbtrackX L2 fmi | GCST90004284 | 1.24 |
| 5534 | Cholesterol to Total Lipids in Very Small VLDL percentage | GCST90500716 | 1.24 |
| 5535 | Duration walking for pleasure | Physical activity | UKBB00000203 | 1.24 |
| 5536 | CEP85 levels | GCST90468716 | 1.24 |
| 5537 | Other disorders of glucose regulation and pancreatic internal secretion | FING00001028 | 1.24 |
| 5538 | aparc-a2009s rh thickness G-postcentral | GCST90003704 | 1.24 |
| 5539 | MMP12 levels | GCST90469916 | 1.24 |
| 5540 | FABP1/RBP2 ratio | GCST90314753 | 1.24 |
| 5541 | Lung cancer | GCST90011812 | 1.24 |
| 5542 | Triglycerides to total lipids ratio in small HDL | GCST90092955 | 1.23 |
| 5543 | MB levels | GCST90469869 | 1.23 |
| 5544 | ARL13B levels | GCST90468363 | 1.23 |
| 5545 | ESAM/TGFB1 ratio | GCST90314718 | 1.23 |
| 5546 | Disorders of other endocrine glands | FING00000450 | 1.23 |
| 5547 | CLEC14A/PTPRS ratio | GCST90314081 | 1.23 |
| 5548 | Metabolic syndrome | GCST90444487 | 1.23 |
| 5549 | MATN3 levels | GCST90469865 | 1.23 |
| 5550 | JAM2/TNFRSF19 ratio | GCST90315241 | 1.23 |
| 5551 | PCDHB15 levels | GCST90470173 | 1.23 |
| 5552 | Neutrophill count | Blood count | UKBB00000497 | 1.23 |
| 5553 | MARCO levels | GCST90469861 | 1.23 |
| 5554 | Fatty acid(20:3)_[M-H]1- levels | GCST90060117 | 1.22 |
| 5555 | aparc-a2009s lh volume S-precentral-sup-part | GCST90002993 | 1.22 |
| 5556 | Cholesterol levels in medium VLDL | GCST90092916 | 1.22 |
| 5557 | EGLN1/PSIP1 ratio | GCST90314620 | 1.22 |
| 5558 | GLOD4/MIF ratio | GCST90314939 | 1.22 |
| 5559 | aparc-pial lh area superiorparietal | GCST90003169 | 1.22 |
| 5560 | MOG/RTBDN ratio | GCST90315476 | 1.22 |
| 5561 | Total lipids in very large VLDL | GCST90500607 | 1.22 |
| 5562 | HSPG2 levels | GCST90469491 | 1.22 |
| 5563 | C-reactive protein levels (UKB data field 30710) | GCST90468064 | 1.22 |
| 5564 | Right-hemisphere somatomotor network to pallidum white-matter structural connectivity | GCST90302797 | 1.22 |
| 5565 | UBE2L6 levels | GCST90471001 | 1.21 |
| 5566 | FN1 levels | GCST90469255 | 1.21 |
| 5567 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 112) | GCST90320931 | 1.21 |
| 5568 | Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers) | FING00000770 | 1.21 |
| 5569 | FBP1/GSTA1 ratio | GCST90314786 | 1.21 |
| 5570 | Triglycerides in small HDL (UKB data field 23578) | GCST90269675 | 1.21 |
| 5571 | AGER levels | GCST90468252 | 1.21 |
| 5572 | DTI autoptx L3 atr l tract | GCST90385195 | 1.21 |
| 5573 | Dry age-related macular degeneration (includes geographic atrophy) | FING00000480 | 1.21 |
| 5574 | Acute appendicitis, no complications | FING00000018 | 1.21 |
| 5575 | Sulcal opening distance of the right calloso-marginal posterior fissure | GCST90104946 | 1.21 |
| 5576 | Left-hemisphere control network to accumbens white-matter structural connectivity | GCST90302758 | 1.21 |
| 5577 | DNAJB14 levels | GCST90240952 | 1.21 |
| 5578 | Omega-3 fatty acid levels | GCST90502422 | 1.21 |
| 5579 | Isoleucine levels | GCST90092843 | 1.20 |
| 5580 | XRCC4 levels | GCST90471085 | 1.20 |
| 5581 | CCL11/CCL2 ratio | GCST90313672 | 1.20 |
| 5582 | PVALB levels | GCST90470393 | 1.20 |
| 5583 | LILRB1 levels | GCST90469776 | 1.20 |
| 5584 | Autorefraction - 3mm asymmetry angle (left) | Eyesight | UKBB00000060 | 1.20 |
| 5585 | A1BG levels | GCST90468185 | 1.20 |
| 5586 | rfMRI connectivity (ICA100 edge 659) | GCST90005512 | 1.20 |
| 5587 | Mood swings | Mental health | UKBB00000482 | 1.20 |
| 5588 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T425 | ECGU000425 | 1.20 |
| 5589 | ENO3 levels | GCST90469111 | 1.19 |
| 5590 | Basophil percentage of granulocytes | GCST004634 | 1.19 |
| 5591 | IDP dMRI TBSS L2 Corticospinal tract R | GCST90004129 | 1.19 |
| 5592 | Volume of right accessory basal nucleus | GCST90475009 | 1.19 |
| 5593 | Cholesterol in Small LDL | GCST90499555 | 1.19 |
| 5594 | Vegetables liking | GCST90094862 | 1.19 |
| 5595 | HGF/MMP8 ratio | GCST90315055 | 1.19 |
| 5596 | Right-hemisphere visual network to right-hemisphere salience/ventral attention network white-matter structural connectivity | GCST90302777 | 1.19 |
| 5597 | IRF2 levels | GCST90241566 | 1.19 |
| 5598 | Linoleic acid levels | GCST90502004 | 1.19 |
| 5599 | METAP2 levels | GCST90469894 | 1.19 |
| 5600 | CEACAM8/PGLYRP1 ratio | GCST90314003 | 1.19 |
| 5601 | PTPN1/SCAMP3 ratio | GCST90315743 | 1.19 |
| 5602 | aparc-DKTatlas lh area precentral | GCST90003256 | 1.19 |
| 5603 | GGT1/IL1RL2 ratio | GCST90314929 | 1.19 |
| 5604 | APRT levels | GCST90468345 | 1.19 |
| 5605 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 127) | GCST90320690 | 1.18 |
| 5606 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T458 | ECGA000458 | 1.18 |
| 5607 | Primary angle-closure glaucoma (PheCode 365.2) | GCST90475876 | 1.18 |
| 5608 | Free Cholesterol to Total Lipids in Small HDL percentage | GCST90499431 | 1.18 |
| 5609 | BAIAP2 levels | GCST90468419 | 1.18 |
| 5610 | Ischemic Heart Disease | circulatory system | UKBB00000381 | 1.18 |
| 5611 | Medication use (antithrombotic agents) | GCST90018762 | 1.18 |
| 5612 | MAVS/SCAMP3 ratio | GCST90315396 | 1.18 |
| 5613 | Urine X-24796 levels in chronic kidney disease | GCST90266800 | 1.18 |
| 5614 | Fracture of rib(s), sternum and thoracic spine | FING00000558 | 1.18 |
| 5615 | TBCC levels | GCST90470814 | 1.18 |
| 5616 | Cholesteryl Esters to Total Lipids in Medium LDL percentage | GCST90498747 | 1.18 |
| 5617 | Elevated prostate specific antigen [PSA] (PheCode 796) | GCST90476277 | 1.18 |
| 5618 | DLL1/IL18BP ratio | GCST90314495 | 1.18 |
| 5619 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T402 | ECGU000402 | 1.18 |
| 5620 | Current tobacco smoking | Smoking | UKBB00000161 | 1.18 |
| 5621 | SH2D1A levels | GCST90470617 | 1.17 |
| 5622 | PM20D1 levels | GCST90470268 | 1.17 |
| 5623 | EDAR/PSRC1 ratio | GCST90314584 | 1.17 |
| 5624 | IDP dMRI TBSS ICVF Tapetum R | GCST90004373 | 1.17 |
| 5625 | DPP6/SEZ6L ratio | GCST90314544 | 1.17 |
| 5626 | Added salt consumption | GCST90133001 | 1.17 |
| 5627 | TGFBR2/THBD ratio | GCST90315916 | 1.17 |
| 5628 | aparc-Desikan rh volume precuneus | GCST90002825 | 1.17 |
| 5629 | Hypothyroidism, drug reimbursement | FING00000655 | 1.17 |
| 5630 | ECM1 levels | GCST90469065 | 1.17 |
| 5631 | Concentration of very large VLDL particles | GCST90500628 | 1.17 |
| 5632 | PDGFA/SPARC ratio | GCST90315620 | 1.17 |
| 5633 | Restless legs syndrome | GCST90435387 | 1.17 |
| 5634 | Polyunsaturated fatty acid levels | GCST90502622 | 1.17 |
| 5635 | IDP dMRI TBSS MD Inferior cerebellar peduncle L | GCST90004038 | 1.17 |
| 5636 | CCN3 levels | GCST90468589 | 1.17 |
| 5637 | Completion of the aide-memoire | GCST90012793 | 1.17 |
| 5638 | EDAR/IRAK4 ratio | GCST90314579 | 1.16 |
| 5639 | NFU1 levels | GCST90470040 | 1.16 |
| 5640 | Phospholipids to Total Lipids in Small LDL percentage | GCST90499700 | 1.16 |
| 5641 | Wears glasses or contact lenses (UKB data field 2207) | GCST90042875 | 1.16 |
| 5642 | CLEC1B/DKK1 ratio | GCST90314088 | 1.16 |
| 5643 | Incisional hernia (PheCode 550.6) | GCST90476064 | 1.16 |
| 5644 | Type 1 diabetes with neurological manifestations (PheCode 250.14) | GCST90475664 | 1.16 |
| 5645 | CHMP1A/RHOC ratio | GCST90314053 | 1.16 |
| 5646 | LAYN/ULBP2 ratio | GCST90315292 | 1.15 |
| 5647 | Alzheimer's disease (MTAG) | GCST90449058 | 1.15 |
| 5648 | IDP T1 FIRST left putamen volume | GCST90002440 | 1.15 |
| 5649 | Total Lipids in Medium LDL | GCST90498806 | 1.15 |
| 5650 | Other disorders of eyelid | FING00001026 | 1.15 |
| 5651 | Acceptance of an invitation to participate in a mental health questionnaire | GCST90012792 | 1.15 |
| 5652 | Concentration of IDL particles | GCST90497606 | 1.15 |
| 5653 | Own or rent accommodation lived in - Rent - from local authority, local council, housing association | Household | UKBB00000624 | 1.15 |
| 5654 | Leisure/social activities - Other group activity | Social support | UKBB00000400 | 1.15 |
| 5655 | APP/CCL28 ratio | GCST90313317 | 1.15 |
| 5656 | Degree of unsaturation | GCST90502225 | 1.14 |
| 5657 | Systolic blood pressure (BMI adjusted) | GCST90335163 | 1.14 |
| 5658 | DAG1 levels | GCST90468943 | 1.14 |
| 5659 | GAL/PM20D1 ratio | GCST90314917 | 1.14 |
| 5660 | IDP T1 FAST ROIs R ventral striatum | GCST90002560 | 1.14 |
| 5661 | TOP1 levels | GCST90470933 | 1.14 |
| 5662 | CRKL/FIS1 ratio | GCST90314266 | 1.14 |
| 5663 | Sphingomyelin_42:2_[M+H]1+ levels | GCST90060403 | 1.14 |
| 5664 | Intended management of patient (recoded) - One or more nights hospital stay | Summary Administration | UKBB00000367 | 1.14 |
| 5665 | Blood cell traits latent factor 7 (white cell) | GCST90559249 | 1.14 |
| 5666 | ENO2/ITGB1BP2 ratio | GCST90314661 | 1.14 |
| 5667 | Mosaic chromosomal alteration of the X chromosome | GCST90165287 | 1.14 |
| 5668 | RGMA levels | GCST90470463 | 1.14 |
| 5669 | X-23641 levels | GCST90200603 | 1.13 |
| 5670 | Brain age gap | GCST90558034 | 1.13 |
| 5671 | Free cholesterol levels in IDL | GCST90092835 | 1.13 |
| 5672 | Triglyceride levels in medium LDL | GCST90092914 | 1.13 |
| 5673 | Triglycerides to Total Lipids in Very Small VLDL percentage | GCST90500886 | 1.13 |
| 5674 | Exposure to tobacco smoke outside home | Smoking | UKBB00000229 | 1.13 |
| 5675 | Sphingomyelin_41:2_[M+H]1+ levels | GCST90060383 | 1.13 |
| 5676 | Frequency of light DIY in last 4 weeks | Physical activity | UKBB00000264 | 1.13 |
| 5677 | Volume of right lateral nucleus | GCST90475034 | 1.13 |
| 5678 | Saturated fatty acid levels | GCST90092980 | 1.13 |
| 5679 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T379 | ECGU000379 | 1.13 |
| 5680 | PAK4 levels | GCST90470150 | 1.13 |
| 5681 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T483 | ECGU000483 | 1.13 |
| 5682 | IDP dMRI ProbtrackX MD fmi | GCST90004230 | 1.13 |
| 5683 | NAGPA levels | GCST90242004 | 1.13 |
| 5684 | NCS1/NPY ratio | GCST90315527 | 1.12 |
| 5685 | Deep endometriosis | FING00000382 | 1.12 |
| 5686 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T15 | ECGA000015 | 1.12 |
| 5687 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T160 | ECGU000160 | 1.12 |
| 5688 | EIF4EBP1 levels | GCST90469095 | 1.12 |
| 5689 | Triglyceride levels in LDL | GCST90092890 | 1.12 |
| 5690 | T1 FreeSurfer DK rh pericalcarine area | GCST90385709 | 1.12 |
| 5691 | CLPS levels | GCST90468786 | 1.12 |
| 5692 | Cholesteryl ester levels in very small VLDL | GCST90093030 | 1.12 |
| 5693 | Left-hemisphere dorsal attention network to right-hemisphere somatomotor network white-matter structural connectivity | GCST90302695 | 1.12 |
| 5694 | Triglyceride to phosphoglyceride ratio | GCST90499996 | 1.11 |
| 5695 | Free cholesterol in large VLDL | GCST90498181 | 1.11 |
| 5696 | TJAP1 levels | GCST90470874 | 1.11 |
| 5697 | rfMRI amplitudes (ICA100 node 45) | GCST90004633 | 1.11 |
| 5698 | Cholesterol in large VLDL (UKB data field 23498) | GCST90269595 | 1.11 |
| 5699 | CD1C/CD207 ratio | GCST90313745 | 1.11 |
| 5700 | Diverticular disease of intestine | FING00000471 | 1.11 |
| 5701 | STK24/TDRKH ratio | GCST90315893 | 1.11 |
| 5702 | Acute alcohol intoxication, ICD10 | FING00000015 | 1.11 |
| 5703 | ARHGEF5 levels | GCST90468360 | 1.11 |
| 5704 | DAB2/FKBP5 ratio | GCST90314363 | 1.10 |
| 5705 | Smoking status - Current | Smoking | UKBB00000779 | 1.10 |
| 5706 | AMOT levels | GCST90468295 | 1.10 |
| 5707 | COL15A1 levels | GCST90468811 | 1.10 |
| 5708 | Red cell distribution width | GCST004621 | 1.10 |
| 5709 | Cholesteryl esters to total lipids ratio in large HDL | GCST90092847 | 1.10 |
| 5710 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T188 | ECGU000188 | 1.10 |
| 5711 | OCLN levels | GCST90470114 | 1.09 |
| 5712 | Amyotrophic lateral sclerosis | GCST90027164 | 1.09 |
| 5713 | Other maternal disorders predominantly related to pregnancy | FING00001069 | 1.09 |
| 5714 | DFFA levels | GCST90468987 | 1.09 |
| 5715 | F3 levels | GCST90469170 | 1.09 |
| 5716 | Total fatty acid levels | GCST90502722 | 1.09 |
| 5717 | Cholesteryl esters in very large VLDL (UKB data field 23492) | GCST90269589 | 1.09 |
| 5718 | Recent trouble relaxing | Anxiety | UKBB00000745 | 1.09 |
| 5719 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T186 | ECGA000186 | 1.09 |
| 5720 | Alzheimer's disease (late onset) | GCST002245 | 1.09 |
| 5721 | Chronic sputum production | GCST90269902 | 1.09 |
| 5722 | IL6ST levels | GCST90469603 | 1.09 |
| 5723 | aseg global volume SupraTentorial | GCST90002595 | 1.08 |
| 5724 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 42) | GCST90320605 | 1.08 |
| 5725 | Alzheimer's disease (MTAG) | GCST90449053 | 1.08 |
| 5726 | ADAM9 levels | GCST90468221 | 1.08 |
| 5727 | CPM/LAMP2 ratio | GCST90314215 | 1.08 |
| 5728 | DTI TBSS L2 Anterior corona radiata L | GCST90384499 | 1.08 |
| 5729 | NFKBIE levels | GCST90470039 | 1.08 |
| 5730 | EDAR/LAT2 ratio | GCST90314582 | 1.08 |
| 5731 | Phlebitis and thrombophlebitis (PheCode 451) | GCST90476003 | 1.08 |
| 5732 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T189 | ECGU000189 | 1.08 |
| 5733 | Pain in thoracic spine | FING00001139 | 1.08 |
| 5734 | MAN2B2 levels | GCST90469844 | 1.08 |
| 5735 | TNFRSF10A levels | GCST90470899 | 1.08 |
| 5736 | SIGLEC7 levels | GCST90470635 | 1.08 |
| 5737 | Encounter for long-term (current) use of anticoagulants (PheCode 286.2) | GCST90475799 | 1.08 |
| 5738 | Bread type: White (UKB data field 1448_1) | GCST90132964 | 1.07 |
| 5739 | FKBP7 levels | GCST90469245 | 1.07 |
| 5740 | Total lipid levels in very small VLDL | GCST90093034 | 1.07 |
| 5741 | ALCAM levels | GCST90468279 | 1.07 |
| 5742 | TNFSF11 levels | GCST90012044 | 1.07 |
| 5743 | aseg rh intensity Accumbens-area | GCST90003788 | 1.07 |
| 5744 | Phospholipids to total lipids ratio in medium LDL | GCST90092913 | 1.07 |
| 5745 | NRSN1 levels | GCST90242062 | 1.07 |
| 5746 | Retinal detachments and breaks | Disorders of choroid and retina | UKBB00000755 | 1.07 |
| 5747 | Congenital malformations of ovaries, fallopian tubes and broad ligaments | FING00000337 | 1.06 |
| 5748 | CNTN5/ROBO2 ratio | GCST90314166 | 1.06 |
| 5749 | MPHOSPH8/USP8 ratio | GCST90315479 | 1.06 |
| 5750 | Total bile acid levels in pregnancy | GCST90454198 | 1.06 |
| 5751 | APPL2 levels | GCST90468343 | 1.06 |
| 5752 | aparc-a2009s lh volume G-precuneus | GCST90002954 | 1.06 |
| 5753 | Cholesterol levels (UKB data field 30690) | GCST90468066 | 1.06 |
| 5754 | MAP2K6 levels | GCST90469852 | 1.06 |
| 5755 | ADAMTSL4 levels | GCST90468229 | 1.06 |
| 5756 | Umbilical hernia (PheCode 550.4) | GCST90476062 | 1.05 |
| 5757 | Able to confide | Social support | UKBB00000004 | 1.05 |
| 5758 | CRH levels | GCST90468862 | 1.05 |
| 5759 | PLTP levels | GCST90470262 | 1.05 |
| 5760 | OBP2B levels | GCST90470113 | 1.05 |
| 5761 | IDP dMRI TBSS ICVF Anterior corona radiata R | GCST90004349 | 1.05 |
| 5762 | Nummular dermatitis | FING00000893 | 1.05 |
| 5763 | Other headache syndromes | FING00001055 | 1.05 |
| 5764 | Chronic ulcer of skin, not elsewhere classified | FING00000300 | 1.05 |
| 5765 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T175 | ECGU000175 | 1.05 |
| 5766 | Pain (limb, back, neck, head abdominally) | FING00001135 | 1.05 |
| 5767 | Cataract (PheCode 366) | GCST90043785 | 1.04 |
| 5768 | Phospholipids in VLDL (UKB data field 23412) | GCST90269509 | 1.04 |
| 5769 | PDGFB/SPARC ratio | GCST90315628 | 1.04 |
| 5770 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T5 | ECGA000005 | 1.04 |
| 5771 | Prescriptions - selective beta1 antagonist|beta blocker | UKBB00000699 | 1.04 |
| 5772 | FKBP1B/PRDX5 ratio | GCST90314833 | 1.04 |
| 5773 | X-21285 levels | GCST90200576 | 1.04 |
| 5774 | Triglyceride to HDL cholesterol ratio | GCST90295953 | 1.04 |
| 5775 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 54) | GCST90320617 | 1.04 |
| 5776 | GPI levels | GCST90241269 | 1.04 |
| 5777 | Strawberries liking | GCST90094849 | 1.04 |
| 5778 | Diastolic blood pressure (BMI adjusted) | GCST90335165 | 1.04 |
| 5779 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T181 | ECGA000181 | 1.04 |
| 5780 | ACE2 levels | GCST90468197 | 1.04 |
| 5781 | Usual walking pace | Physical activity | UKBB00000891 | 1.04 |
| 5782 | Retinal detachments and breaks | FING00001260 | 1.04 |
| 5783 | Other and unspecified urticaria | FING00000957 | 1.04 |
| 5784 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T400 | ECGA000400 | 1.04 |
| 5785 | N-palmitoyl-heptadecasphingosine (d17:1/16:0) levels | GCST90200115 | 1.03 |
| 5786 | F10 levels | GCST90469163 | 1.03 |
| 5787 | ICD10 O13: Gestational hypertension | GCST90454232 | 1.03 |
| 5788 | Body mass index | GCST90103751 | 1.03 |
| 5789 | T1 CAT volume L IX | GCST90384133 | 1.03 |
| 5790 | aparc-pial rh area caudalmiddlefrontal | GCST90003177 | 1.03 |
| 5791 | 1-palmitoyl-2-oleoyl-GPE (16:0/18:1) metabolite level | GCST90616403 | 1.03 |
| 5792 | Nonspecific chest pain | circulatory system | UKBB00000527 | 1.03 |
| 5793 | HDL x anxiety interaction (2df test) | GCST90570665 | 1.03 |
| 5794 | FGF2 levels | GCST90469224 | 1.03 |
| 5795 | SCGB3A1 levels | GCST90470542 | 1.03 |
| 5796 | TEK levels | GCST90470829 | 1.03 |
| 5797 | Urine N-acetyl-cadaverine levels in chronic kidney disease | GCST90265541 | 1.03 |
| 5798 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 75) | GCST90320894 | 1.02 |
| 5799 | SERPIND1 levels | GCST90470595 | 1.02 |
| 5800 | Total lipid levels in lipoprotein particles | GCST90092989 | 1.02 |
| 5801 | Radiculopathy | FING00001238 | 1.02 |
| 5802 | Soya milk liking | GCST90094845 | 1.02 |
| 5803 | PEAR1 levels | GCST90470204 | 1.02 |
| 5804 | Direct low density lipoprotein levels (UKB data field 30780) | GCST90468080 | 1.02 |
| 5805 | Frailty (General Factor) | GCST90624046 | 1.02 |
| 5806 | CEP43/WASF1 ratio | GCST90314023 | 1.02 |
| 5807 | Operation code - caesarean section / caesarian section | Operations | UKBB00000552 | 1.02 |
| 5808 | SEMA3G levels | GCST90470571 | 1.02 |
| 5809 | Triglycerides to total lipids ratio in chylomicrons and extremely large VLDL | GCST90093051 | 1.02 |
| 5810 | CD200 levels | GCST90468606 | 1.02 |
| 5811 | Cardiovascular disease | GCST90086057 | 1.02 |
| 5812 | Pollock liking | GCST90094813 | 1.01 |
| 5813 | Right-hemisphere somatomotor network to hippocampus white-matter structural connectivity | GCST90302798 | 1.01 |
| 5814 | wg rh intensity-contrast superiortemporal | GCST90003856 | 1.01 |
| 5815 | CD300C/NBL1 ratio | GCST90313792 | 1.01 |
| 5816 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T190 | ECGU000190 | 1.01 |
| 5817 | EGFR levels | GCST90469085 | 1.01 |
| 5818 | RRM2B levels | GCST90470500 | 1.01 |
| 5819 | SPINK5/SPINT1 ratio | GCST90315877 | 1.01 |
| 5820 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T187 | ECGA000187 | 1.01 |
| 5821 | Pulmonary embolism | FING00001228 | 1.01 |
| 5822 | Phosphatidylethanolamine (18:0_18:1) levels | GCST90024977 | 1.01 |
| 5823 | IDP T1 SIENAX brain-unnormalised volume | GCST90002435 | 1.01 |
| 5824 | Left-hemisphere default mode network to right-hemisphere salience/ventral attention network white-matter structural connectivity | GCST90302763 | 1.00 |
| 5825 | MAVS levels | GCST90469866 | 1.00 |
| 5826 | Intraocular pressure (confirmatory factor analysis Factor 26) | GCST90309360 | 1.00 |
| 5827 | LRRC25 levels | GCST90469801 | 1.00 |
| 5828 | Chronic obstructive pulmonary disease x current smoker interaction (main effect) | GCST90016591 | 1.00 |
| 5829 | AZU1/CEACAM8 ratio | GCST90313424 | 1.00 |
| 5830 | DTI autoptx MD fma tract | GCST90385230 | 1.00 |
| 5831 | Heart attack | GCST90475211 | 0.99 |
| 5832 | IGFBP7 levels | GCST90469532 | 0.99 |
| 5833 | Pain in joint (PheCode 745) | GCST90476262 | 0.99 |
| 5834 | F-cooking flavour liking (derived food-liking factor) | GCST90094742 | 0.99 |
| 5835 | AXIN1/INPPL1 ratio | GCST90313410 | 0.99 |
| 5836 | LGALS1 levels | GCST90469759 | 0.99 |
| 5837 | DTI TBSS FA Sagittal stratum L | GCST90384411 | 0.99 |
| 5838 | Acetate levels | GCST90092803 | 0.99 |
| 5839 | KHK levels | GCST90469675 | 0.99 |
| 5840 | Cholesterol levels in very small VLDL | GCST90093028 | 0.99 |
| 5841 | aparc-a2009s lh volume G-front-inf-Opercular | GCST90002936 | 0.99 |
| 5842 | Testosterone levels | GCST90483486 | 0.99 |
| 5843 | PTPRC levels | GCST90470380 | 0.99 |
| 5844 | TNFRSF13B/TNFRSF13C ratio | GCST90315931 | 0.99 |
| 5845 | Concentration of VLDL particles (UKB data field 23428) | GCST90269525 | 0.98 |
| 5846 | CD27/ICAM3 ratio | GCST90313773 | 0.98 |
| 5847 | Main speciality of consultant (recoded) - Trauma and orthopaedics | Summary Administration | UKBB00000420 | 0.98 |
| 5848 | Irritable bowel syndrome mixed subtype | GCST90243959 | 0.98 |
| 5849 | Chronotype | GCST003837 | 0.98 |
| 5850 | Total lipid levels in VLDL | GCST90092999 | 0.98 |
| 5851 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T8 | ECGA000008 | 0.98 |
| 5852 | Cholesteryl Esters to Total Lipids in Small HDL percentage | GCST90499403 | 0.98 |
| 5853 | MARS1 levels | GCST90469862 | 0.98 |
| 5854 | Volume of left central nucleus | GCST90474958 | 0.98 |
| 5855 | Dried fruit intake | Diet | UKBB00000193 | 0.98 |
| 5856 | DTI TBSS L2 Anterior corona radiata R | GCST90384498 | 0.98 |
| 5857 | Volume of right medial nucleus | GCST90475045 | 0.98 |
| 5858 | DKK1/SERPINE1 ratio | GCST90314480 | 0.98 |
| 5859 | Total free cholesterol levels | GCST90092988 | 0.98 |
| 5860 | PCOLCE levels | GCST90470175 | 0.98 |
| 5861 | Valine levels | GCST90500176 | 0.98 |
| 5862 | FGF21 levels | GCST90469222 | 0.98 |
| 5863 | Principal component-derived dietary pattern 31 | GCST90133036 | 0.97 |
| 5864 | ICAM1/REG1A ratio | GCST90315114 | 0.97 |
| 5865 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T403 | ECGA000403 | 0.97 |
| 5866 | Takes medication for prostate cancer? | GCST90475187 | 0.97 |
| 5867 | UNC5D levels | GCST90471010 | 0.97 |
| 5868 | RND3 levels | GCST90422230 | 0.97 |
| 5869 | STK11 levels | GCST90470765 | 0.97 |
| 5870 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T394 | ECGA000394 | 0.97 |
| 5871 | Linoleic acid levels | GCST90502012 | 0.97 |
| 5872 | Morning/evening person (chronotype) | Sleep | UKBB00000483 | 0.97 |
| 5873 | HippSubfield rh volume subiculum-head | GCST90002693 | 0.97 |
| 5874 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T224 | ECGU000224 | 0.96 |
| 5875 | Glycerophosphorylcholine (GPC) levels | GCST90199629 | 0.96 |
| 5876 | Free cholesterol to total lipids ratio in large HDL | GCST90092849 | 0.96 |
| 5877 | Chronic obstructive pulmonary disease in non-current smokers | GCST90016594 | 0.96 |
| 5878 | Eosinophil percentage of white cells variance | GCST90565690 | 0.96 |
| 5879 | CXCL17/SFTPA2 ratio | GCST90314341 | 0.96 |
| 5880 | Hippocampal right HATA volume | GCST90267969 | 0.96 |
| 5881 | MYOC levels | GCST90469983 | 0.96 |
| 5882 | IGDCC4 levels | GCST90469523 | 0.96 |
| 5883 | Urine 5-acetylamino-6-amino-3-methyluracil levels in chronic kidney disease | GCST90264674 | 0.95 |
| 5884 | Biliary cirrhosis, NAS | FING00000213 | 0.95 |
| 5885 | Bread type - White | Diet | UKBB00000106 | 0.95 |
| 5886 | Glomerular filtration rate (cystatin C) | GCST003375 | 0.95 |
| 5887 | IDP dMRI TBSS ICVF Genu of corpus callosum | GCST90004329 | 0.95 |
| 5888 | TST levels | GCST90470982 | 0.95 |
| 5889 | IGFBPL1 levels | GCST90179323 | 0.95 |
| 5890 | GLT25D1 levels | GCST90426421 | 0.95 |
| 5891 | aparc-a2009s rh area G-precentral | GCST90003399 | 0.95 |
| 5892 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T9 | ECGA000009 | 0.95 |
| 5893 | Urine X-23518 levels in chronic kidney disease | GCST90266595 | 0.95 |
| 5894 | aparc-Desikan lh thickness precentral | GCST90003468 | 0.95 |
| 5895 | Phospholipids to total lipids ratio in medium HDL | GCST90092901 | 0.95 |
| 5896 | Pollinosis | GCST90018683 | 0.95 |
| 5897 | Left-hemisphere visual network to right-hemisphere limbic network white-matter structural connectivity | GCST90302659 | 0.95 |
| 5898 | Ovarian cyst | FING00001132 | 0.95 |
| 5899 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 33) | GCST90320596 | 0.94 |
| 5900 | Autorefraction - 3mm strong meridian angle (left) | Eyesight | UKBB00000067 | 0.94 |
| 5901 | Mood [affective] disorders | FING00000836 | 0.94 |
| 5902 | Disorders of vestibular function (Vertigo) | FING00000464 | 0.94 |
| 5903 | Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers) | FING00000766 | 0.94 |
| 5904 | Total Lipids in HDL | GCST90497401 | 0.94 |
| 5905 | T1 FreeSurfer aseg Left-Caudate | GCST90384144 | 0.94 |
| 5906 | SIGLEC5 levels | GCST90470633 | 0.94 |
| 5907 | Triglycerides in large VLDL | GCST90498280 | 0.94 |
| 5908 | Urine glycocholenate sulfate* levels in chronic kidney disease | GCST90265292 | 0.94 |
| 5909 | X-13671 levels | GCST90243829 | 0.94 |
| 5910 | CXCL16 levels | GCST90240524 | 0.94 |
| 5911 | Phenylalanine levels (UKB data field 23468) | GCST90269565 | 0.94 |
| 5912 | VMO1 levels | GCST90471042 | 0.93 |
| 5913 | aseg rh volume CerebralWhiteMatter | GCST90002632 | 0.93 |
| 5914 | Volume of left medial nucleus | GCST90474892 | 0.93 |
| 5915 | Biological Grandparent (paternal): Diabetes / Sugar | GCST90475549 | 0.93 |
| 5916 | Polyunsaturated fatty acid levels | GCST90502140 | 0.93 |
| 5917 | Cholesterol to Total Lipids in Small HDL percentage | GCST90499369 | 0.93 |
| 5918 | aparc-Desikan rh area superiorparietal | GCST90003135 | 0.93 |
| 5919 | IL27 levels | GCST90012017 | 0.93 |
| 5920 | Sphingomyelin levels | GCST90092982 | 0.93 |
| 5921 | CXCL11 levels | GCST90468924 | 0.93 |
| 5922 | IRAK4/VASH1 ratio | GCST90315201 | 0.93 |
| 5923 | BA-exvivo lh thickness BA2 | GCST90003514 | 0.93 |
| 5924 | Cholesteryl ester levels in chylomicrons and extremely large VLDL | GCST90500943 | 0.93 |
| 5925 | hemoglobin (maximum, inv-norm transformed) | GCST90475372 | 0.93 |
| 5926 | CXCL5/MESD ratio | GCST90314350 | 0.93 |
| 5927 | Concentration of medium HDL particles (UKB data field 23565) | GCST90269662 | 0.93 |
| 5928 | ACP5 levels | GCST90468203 | 0.93 |
| 5929 | red cell diameter width (RDW, maximum, inv-norm transformed) | GCST90476357 | 0.93 |
| 5930 | CALCOCO2 levels | GCST90468531 | 0.93 |
| 5931 | Autorefraction - 6mm asymmetry index (left) | Eyesight | UKBB00000073 | 0.93 |
| 5932 | aparc-a2009s rh area G-precuneus | GCST90003400 | 0.92 |
| 5933 | Triglyceride levels in IDL | GCST90092841 | 0.92 |
| 5934 | Triglyceride levels in chylomicrons and extremely large VLDL | GCST90132630 | 0.92 |
| 5935 | Total concentration of lipoprotein particles | GCST90500101 | 0.92 |
| 5936 | ERBB2/GUSB ratio | GCST90314687 | 0.92 |
| 5937 | CNDP1 levels | GCST90468796 | 0.92 |
| 5938 | ACVRL1/EFNA4 ratio | GCST90313156 | 0.92 |
| 5939 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T283 | ECGU000283 | 0.92 |
| 5940 | ARF6 levels | GCST90468348 | 0.92 |
| 5941 | TRIM40 levels | GCST90470968 | 0.92 |
| 5942 | Mean arterial pressure (BMI adjusted) | GCST90335169 | 0.92 |
| 5943 | APEX1/LSP1 ratio | GCST90313307 | 0.92 |
| 5944 | T1 FreeSurfer DK lh MeanThickness thickness | GCST90385656 | 0.92 |
| 5945 | Cholesteryl ester levels in medium VLDL | GCST90092918 | 0.92 |
| 5946 | Arterial stiffness index | GCST008403 | 0.91 |
| 5947 | IDP dMRI ProbtrackX L3 fmi | GCST90004311 | 0.91 |
| 5948 | IDP dMRI TBSS MD Genu of corpus callosum | GCST90004029 | 0.91 |
| 5949 | BCAM/CDH5 ratio | GCST90313469 | 0.91 |
| 5950 | aparc-a2009s rh thickness Pole-temporal | GCST90003719 | 0.91 |
| 5951 | aseg global volume BrainSegNotVentSurf | GCST90002592 | 0.91 |
| 5952 | Biological Mother: Cancer, Skin | GCST90475487 | 0.91 |
| 5953 | VSIG2 levels | GCST90471051 | 0.91 |
| 5954 | aparc-Desikan rh volume superiorparietal | GCST90002829 | 0.91 |
| 5955 | Current employment status - In paid employment or self-employed | Employment | UKBB00000158 | 0.91 |
| 5956 | Type 2 diabetes | GCST010118 | 0.91 |
| 5957 | Mean corpuscular hemoglobin concentration | GCST90018745 | 0.91 |
| 5958 | BA-exvivo rh area BA4a | GCST90003225 | 0.90 |
| 5959 | Shoulder lesions | FING00001303 | 0.90 |
| 5960 | CST3/TFF3 ratio | GCST90314299 | 0.90 |
| 5961 | SEZ6L levels | GCST90470607 | 0.90 |
| 5962 | HippSubfield rh volume presubiculum-head | GCST90002695 | 0.90 |
| 5963 | TRIM21 levels | GCST90470964 | 0.90 |
| 5964 | Gastric ulcer | GCST90270927 | 0.90 |
| 5965 | Illnesses of siblings - Diabetes | Family history | UKBB00000350 | 0.90 |
| 5966 | Triglycerides in LDL | GCST90498469 | 0.90 |
| 5967 | aseg lh number HolesBeforeFixing | GCST90002630 | 0.90 |
| 5968 | CPB1 levels | GCST90240597 | 0.90 |
| 5969 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T402 | ECGA000402 | 0.90 |
| 5970 | CX3CL1 levels | GCST90012074 | 0.90 |
| 5971 | Oral glucose tolerance test-0h | GCST90297788 | 0.90 |
| 5972 | Triglyceride levels | GCST90278645 | 0.90 |
| 5973 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T378 | ECGU000378 | 0.90 |
| 5974 | 1-linoleoyl-GPI (18:2) levels | GCST90199821 | 0.90 |
| 5975 | SEMA4D levels | GCST90470573 | 0.90 |
| 5976 | Potatoes liking | GCST90094816 | 0.90 |
| 5977 | Endometriosis | FING00000497 | 0.89 |
| 5978 | LTBP2/MYOC ratio | GCST90315337 | 0.89 |
| 5979 | white blood cell count (WBC, mean, inv-norm transformed) | GCST90476454 | 0.89 |
| 5980 | Phospholipid levels in very small VLDL | GCST90093036 | 0.89 |
| 5981 | Frailty (Factor 1 - Limited Social Support) | GCST90624047 | 0.89 |
| 5982 | CKMB levels | GCST90475221 | 0.89 |
| 5983 | Cholesterol to Total Lipids in Very Large VLDL percentage | GCST90500542 | 0.89 |
| 5984 | FLT3LG levels | GCST90469250 | 0.89 |
| 5985 | Total cholesterol levels | GCST90500015 | 0.89 |
| 5986 | CRTAC1 levels | GCST90468870 | 0.89 |
| 5987 | TYRO3 levels | GCST90470997 | 0.88 |
| 5988 | aseg lh volume Hippocampus | GCST90002624 | 0.88 |
| 5989 | Total fatty acids levels (UKB data field 23442) | GCST90269539 | 0.88 |
| 5990 | CPB1/CTRB1 ratio | GCST90314208 | 0.88 |
| 5991 | aparc-DKTatlas lh thickness precentral | GCST90003562 | 0.88 |
| 5992 | TNFRSF10C levels | GCST90470901 | 0.88 |
| 5993 | Ventral hernia (PheCode 550.5) | GCST90476063 | 0.88 |
| 5994 | Other chondrocalcinosis | FING00000977 | 0.88 |
| 5995 | BMP7 levels | GCST90088157 | 0.88 |
| 5996 | LYN levels | GCST90469826 | 0.88 |
| 5997 | Phospholipids to Total Lipids in Very Large VLDL percentage | GCST90500655 | 0.88 |
| 5998 | RAB2B levels | GCST90470406 | 0.88 |
| 5999 | aseg rh intensity Caudate | GCST90003783 | 0.88 |
| 6000 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T177 | ECGA000177 | 0.88 |